Stereotactic Body Radiation

RADIATION12 trials

Conditions

Advanced Pancreatic CancerCarcinoma, HepatocellularHepatocellular CarcinomaLiver MetastasisLung CancerNon Small Cell Lung CancerPancreatic CancerPancreatic Neoplasms

Phase 1

Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC)

TerminatedNCT00672178

Duke UniversityRenal Cell Carcinoma

Start: 2008-03-31End: 2009-09-30Updated: 2017-01-12

Phase 2

Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)

CompletedNCT00914355

University Health Network, TorontoHepatocellular Carcinoma

Start: 2007-08-31End: 2020-12-08Updated: 2021-10-06

Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3)

CompletedNCT00914615

University Health Network, TorontoLiver Metastasis

Start: 2007-08-31End: 2020-08-07Updated: 2021-10-06

FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer

TerminatedNCT01439542

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sProstate Cancer

Start: 2011-09-30End: 2017-11-30Updated: 2018-08-09

Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas

CompletedNCT01595321

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPancreatic Cancer

Start: 2012-10-29End: 2023-10-18Updated: 2024-08-14

SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer

Not yet recruitingNCT06422156

Peking University Third HospitalAdvanced Pancreatic Cancer

Start: 2024-06-01End: 2026-06-01Target: 73Updated: 2024-05-20

Phase 3

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

RecruitingNCT03895359

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sHepatocellular Carcinoma

Start: 2019-05-27End: 2027-06-01Target: 128Updated: 2025-03-11

Unknown Phase

Dose Escalation Study for Primary Hepatocellular Carcinoma

CompletedNCT00243841

Indiana University School of MedicineCarcinoma, Hepatocellular

Start: 2004-05-31End: 2016-12-31Updated: 2018-12-13

Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung

CompletedNCT00832780

New Mexico Cancer Research AllianceLung Cancer, Non Small Cell Lung Cancer, Solid Tumors

Start: 2008-01-31End: 2018-12-31Updated: 2021-05-21

Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways

CompletedNCT01051037

Jonsson Comprehensive Cancer CenterLung Cancer

Start: 2010-02-08End: 2017-12-20Updated: 2019-05-06

Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region

CompletedNCT02780648

Indiana UniversityPancreatic Neoplasms

Start: 2016-05-01End: 2025-05-15Updated: 2025-11-03

A pilot study to determine the feasibility of Stereotactic Body Radiation Therapy following Chemotherapy for Unresectable perihilar CholangioCarcinoma

RecruitingNL-OMON45647

Erasmus MC, Universitair Medisch Centrum Rotterdamcholangiocarcinoma perihilar

Start: 2017-11-08Updated: 2024-02-28

Related Papers

Final results of a phase II trial of stereotactic body radiotherapy (SBRT) in patients with hepatocellular carcinoma (HCC) with Child-Pugh class A (CPC-A).

Journal of Clinical Oncology2014-05-20